139 GPS’ PERSPECTIVES ABOUT REMOTE DERMATOLOGY CARE DURING THE COVID-19 PANDEMIC Responses to additional insight questions Closed-ended responses to the additional insight questions are presented in Table 7.3. Most GPs (42/66, 64%) reported that they used the telemedicine platform approximately as often during the first COVID-19 wave as in the period before the COVID-19 pandemic, whereas 23% (15/66) of the GPs used the telemedicine platform more often. Of the 66 GPs, 46 (70%) GPs used the telemedicine platform at the time of this study as often as before the pandemic, and 16 (24%) GPs used the platform more frequently. Of the 66 GPs, 40 (61%) had (strongly) positive experiences with the use of digital dermatology during the pandemic. Almost all GPs (60/66, 91%) received sufficient support to provide digital care. Of the 66 GPs, 63 (95%) took the (dermoscopic) photographs during a teledermatology or teledermoscopy consultation themselves. Of the 66 GPs, only 30 (45%) received training or instructions about taking (dermoscopic) photographs from the telemedicine organization, 7 (11%) took an (additional) imaging course (e.g., dermoscopy and medical imaging), and 13 (20%) gained experience in taking (dermoscopic) images in daily practice. Of the 66 GPs, 25 (38%) GPs did not receive any training or instruction, and 15 (60%) of them did not judge this training or instruction as necessary. Of the 66 GPs, 60 (91%) felt (strongly) confident and 5 (8%) felt “neutral” confident in determining the patient’s treatment policy after a teledermatology or teledermoscopy consultation (based on the advice and diagnosis received from the dermatologist). GPs primarily use digital dermatology consultations to prevent physical referrals of their patients to a dermatologist (54/66, 82%). Table 7.3: GPs’a responses to additional insight questions (n=66). Questions and response options GPs, n (%) Platform use during the first COVID-19 waveb compared with before the COVID-19 pandemic Less often 9 (14) Approximately as often 42 (64) More often 15 (23) Not applicable 0 (0) Currentc platform use compared with that during the period before the COVID-19 pandemic Less often 3 (5) Approximately as often 46 (70) More often 16 (24) Not applicable 1 (2) Received sufficient support to provide digital care during the COVID-19 pandemic Yes 60 (91) No 6 (9) Experiences regarding consultations in digital dermatology care pathway during the COVID19 pandemic Strongly negative 0 (0) Negative 3 (5) Neutral 18 (27) 7
RkJQdWJsaXNoZXIy MTk4NDMw